Skip to content

13F-HR filed by Avidity Partners Management LP

Avidity Partners Management LP filed this 13F-HR for the quarter ended 2025-09-30, filed 2025-11-14, with 43 holding rows worth $439,394,999.

Accession
0001791827-25-000008
Filed
2025-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2025

A holdings report, 43 entries on the cover page, a total value of $439,394,999 stated on the cover page (in dollars after the unit check, H1), rows summing to $439,394,999 with VALUE read as dollars as filed, 13F file number 028-20028. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
DIANTHUS THERAPEUTICS INC252828108COM3,204,184$126,084,640dollars as filed
CG ONCOLOGY INC156944100COMMON STOCK1,600,899$64,484,212dollars as filed
Medtronic PlcG5960L103COM190,600$18,152,744dollars as filed
Boston Scientific Corporation101137107COM164,300$16,040,609dollars as filed
ORUKA THERAPEUTICS INC COM687604108Stock660,424$12,699,954dollars as filed
Bristol-Myers Squibb Company110122108COM257,600$11,617,760dollars as filed
NATERA INC COM632307104Stock70,400$11,332,288dollars as filed
Danaher Corporation235851102COM54,700$10,844,822dollars as filed
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR510,000$10,302,000dollars as filed
PERSPECTIVE THERAPEUTICS INC46489V302COMMON STOCK2,994,033$10,269,533dollars as filed
JADE BIOSCIENCES INC008064206COM NEW1,127,186$9,727,615dollars as filed
Pfizer Inc.717081103COM366,400$9,335,872dollars as filed
Thermo Fisher Scientific Inc.883556102COM18,900$9,166,878dollars as filed
CONTEXT THERAPEUTICS INC21077P108COM8,981,855$8,701,621dollars as filed
GENMAB A/S372303206Ordinary Shares, nominal value DKK 1 per share248,100$7,609,227dollars as filed
METSERA INC59267L107COM140,500$7,352,365dollars as filed
UnitedHealth Group Inc91324P102COM17,800$6,146,340dollars as filed
ARVINAS INC04335A105COM698,363$5,950,053dollars as filed
CENCORA INC COM03073E105Stock19,000$5,938,070dollars as filed
ENCOMPASS HEALTH CORP COM29261A100Stock41,900$5,322,138dollars as filed
Johnson & Johnson478160104COM26,800$4,969,256dollars as filed
Cigna Corporation125523100COM16,600$4,784,950dollars as filed
AbbVie,Inc.00287Y109COM19,800$4,584,492dollars as filed
MCKESSON CORP COM58155Q103Stock5,800$4,480,732dollars as filed
CARLSMED INC14280C105COMMON STOCK321,912$4,310,402dollars as filed
KENVUE INC49177J102COM265,200$4,304,196dollars as filed
IMMUNIC INC4525EP101COM4,699,411$4,143,001dollars as filed
ARCUTIS BIOTHERAPEUTICS INC03969K108COM214,400$4,041,440dollars as filed
EXACT SCIENCES CORP COM30063P105Stock73,600$4,026,656dollars as filed
PHATHOM PHARMACEUTICALS INC71722W107COMMON STOCK306,000$3,601,620dollars as filed
REPLIGEN CORP COM759916109Stock23,300$3,114,511dollars as filed
ACADIA PHARMACEUTICALS INC004225108COM144,000$3,072,960dollars as filed
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR14,500$2,882,745dollars as filed
ENLIVEN THERAPEUTICS INC COM29337E102Stock140,300$2,871,941dollars as filed
BEAM THERAPEUTICS INC07373V105COM112,000$2,718,240dollars as filed
SCYNEXIS INC811292200COM NEW3,350,528$2,579,907dollars as filed
HEALTHEQUITY INC COM42226A107Stock25,300$2,397,681dollars as filed
WAVE LIFE SCIENCES LTD SHSY95308105Stock297,500$2,177,700dollars as filed
XENON PHARMACEUTICALS INC COM98420N105Stock53,400$2,144,010dollars as filed
AKERO THERAPEUTICS INC00973Y108COM40,500$1,922,940dollars as filed
INSMED INC COM PAR $.01457669307Stock11,600$1,670,516dollars as filed
KARYOPHARM THERAPEUTICS INC48576U205COMMON STOCK134,566$880,062dollars as filed
IMMUNEERING CORP45254E107CLASS A COM90,900$636,300dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001791827-25-000008this filing2025-11-14acceptance time not in the bulk data set